Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Non-Current Deffered Revenue (2016 - 2019)

Enanta Pharmaceuticals filings provide 8 years of Non-Current Deffered Revenue readings, the most recent being $900000.0 for Q3 2019.

  • On a quarterly basis, Non-Current Deffered Revenue rose 51.77% to $900000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $900000.0, a 51.77% increase, with the full-year FY2019 number at $900000.0, up 51.77% from a year prior.
  • Non-Current Deffered Revenue hit $900000.0 in Q3 2019 for Enanta Pharmaceuticals, down from $923000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $923000.0 in Q2 2019 to a low of $161000.0 in Q1 2015.
  • Median Non-Current Deffered Revenue over the past 5 years was $674000.0 (2018), compared with a mean of $650789.5.
  • Biggest five-year swings in Non-Current Deffered Revenue: soared 322.22% in 2015 and later fell 14.06% in 2018.
  • Enanta Pharmaceuticals' Non-Current Deffered Revenue stood at $646000.0 in 2015, then increased by 8.51% to $701000.0 in 2016, then fell by 6.7% to $654000.0 in 2017, then increased by 3.06% to $674000.0 in 2018, then surged by 33.53% to $900000.0 in 2019.
  • The last three reported values for Non-Current Deffered Revenue were $900000.0 (Q3 2019), $923000.0 (Q2 2019), and $842000.0 (Q1 2019) per Business Quant data.